SYFOVRE
Total Payments
$106,869
Transactions
78
Doctors
41
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $106,869 | 78 | 41 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $106,438 | 63 | 99.6% |
| Food and Beverage | $356.09 | 12 | 0.3% |
| Travel and Lodging | $74.18 | 3 | 0.1% |
Top Doctors Receiving Payments for SYFOVRE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Ophthalmology | Plymouth Meeting, PA | $10,860 | 1 |
| , M.D., M.S | Ophthalmology | Manassas, VA | $9,158 | 2 |
| , MD | Ophthalmology | Great Neck, NY | $6,804 | 2 |
| , MD MHSC | Ophthalmology | New Brunswick, NJ | $5,604 | 2 |
| , MD | Ophthalmology | Great Neck, NY | $5,430 | 1 |
| , MD | Retina Specialist | Teaneck, NJ | $4,730 | 1 |
| , M.D | Retina Specialist | Cleveland, OH | $4,730 | 1 |
| , OD | Optometrist | Sepulveda, CA | $4,466 | 3 |
| , M.D., M.B.A | Ophthalmology | Miami, FL | $3,784 | 4 |
| , M.D | Ophthalmology | Beachwood, OH | $3,780 | 1 |
| , M.D | Retina Specialist | Springfield, IL | $3,780 | 1 |
| , MD | Retina Specialist | New York, NY | $3,311 | 3 |
| , MD | Ophthalmology | Baltimore, MD | $3,311 | 3 |
| , MD | Ophthalmology | Royal Oak, MI | $2,838 | 1 |
| , MD | Ophthalmology | Boston, MA | $2,646 | 3 |
| , MD | Ophthalmology | Boston, MA | $2,646 | 3 |
| , MD | Ophthalmology | Atlanta, GA | $2,308 | 3 |
| , M.D | Retina Specialist | Burleson, TX | $2,268 | 1 |
| , M.D | Internal Medicine | Cleveland, OH | $2,268 | 1 |
| , MD | Ophthalmology | Schertz, TX | $2,268 | 1 |
| , MD | Ophthalmology | Los Angeles, CA | $2,172 | 2 |
| , MD | Optometrist | Norfolk, VA | $1,965 | 2 |
| , M.D | Retina Specialist | Manchester, CT | $1,890 | 1 |
| , M.D | Ophthalmology | Rochester, MN | $1,629 | 2 |
| , MD | Ophthalmology | Santa Ana, CA | $1,443 | 1 |
Ad
Manufacturing Companies
- Apellis Pharmaceuticals, Inc. $106,869
Product Information
- Type Drug
- Total Payments $106,869
- Total Doctors 41
- Transactions 78
About SYFOVRE
SYFOVRE is a drug associated with $106,869 in payments to 41 healthcare providers, recorded across 78 transactions in the CMS Open Payments database. The primary manufacturer is Apellis Pharmaceuticals, Inc..
Payment data is available from 2023 to 2023. In 2023, $106,869 was paid across 78 transactions to 41 doctors.
The most common payment nature for SYFOVRE is "Consulting Fee" ($106,438, 99.6% of total).